{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T17:12:48Z","timestamp":1722273168233},"reference-count":0,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,10]]},"DOI":"10.7759\/cureus.3277","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T03:34:45Z","timestamp":1536636885000},"source":"Crossref","is-referenced-by-count":1,"title":["Survival as a Function of Nonsteroidal Anti-inflammatory Drug Use in Patients with Glioblastoma"],"prefix":"10.1007","author":[{"given":"Ryan P","family":"Bruhns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whitney S","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Torabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Borgstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Roussas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lemole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/14603-survival-as-a-function-of-nonsteroidal-anti-inflammatory-drug-use-in-patients-with-glioblastoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T17:13:14Z","timestamp":1707498794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/14603-survival-as-a-function-of-nonsteroidal-anti-inflammatory-drug-use-in-patients-with-glioblastoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7759\/cureus.3277","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,10]]}}}